Searched for
AMLODIPINE BESYLATE TABLETS
Sensex down over 300 points, Nifty tests 7,550; NCC down 7%The S&P BSE Sensex fell over 100 points amid high volatility witnsessed in trade on Monday.- Twelve stocks in focus in Monday's tradeIndian markets are expected to trade lower. Here is a list of twelve stocks which are likely to remain in focus today.
- Dr Reddy's recalls over 55K bottles of hypertension drug in USDr Reddy's Laboratories is recalling over 55,000 bottles of Amlodipine besylate and Atorvastatin calcium tablets.
- Wockhardt recalls over 50 lakh bottles of various drugs in USAs per the information available on the USFDA, Wockhardt is recalling the drugs for current good manufacturing practice (CGMP) deviations.
- Wockhardt recalls over 1.62 lakh cartons of drugs in USs per the information available on the US Food and Drug Administration's (USFDA) website, Mumbai-based Wockhardt is recalling the drugs for...
- Dr Reddy's Laboratories recalls anti-seizure, hypertension drugs from US marketThe firm has started recalling Divalproex Sodium extended-release tablets as it has failed dissolution tests.
- Sensex rangebound, Nifty off lows; top ten stocks in focusSensex managed to recoup losses after falling as much as 63 points in trade on Tuesday, led by gains in TCS, ICICI Bank, Infosys, Sun Pharm...
- Eleven stocks in focus in Tuesday morning tradeIndian markets are expected to trade in a range. Here is a list of eleven stocks which are likely to be in focus today.
- Cadila Healthcare recalls 15,144 bottles of hypertension drug in USAs per information available on the USFDA website, Zydus Pharmaceuticals USA Inc, the US-based arm of the company, is recalling the drug du...
- Dr Reddy's launches generic cholesterol-lowering drug in USDr Reddy's Laboratories shares were trading at Rs 2,594 apiece on the BSE in afternoon trade, down 1.60 per cent from its previous close.
- Unichem gets USFDA nod for generic hypertension tabletsUnichem Laboratories today said it has received approval from the US health regulator USFDA for its generic amlodipine besylate tablets use...
- Zydus receives anti-hypertensive drug approvalZydus Cadila has received tentative approval from the US drug authorities for two anti-hypertensive drugs.
- Ranbaxy Laboratories launches generic Cadeut in the American marketDrug firm Ranbaxy Laboratories on Tuesday launched a generic version of Caduet, used for treating cardio vascular diseases, in the US marke...
- Wockhardt gets FDA nod to enter US Norvasc marketWockhardt has launched Amlodipine tablets in US market. The tablets are in strengths of 2.5 mg, 5 mg and 10 mg. The US market for Amlodipin...
- Lupin gets US nod for hypertension drugThe company's Amlodipine Besylate tablets are AB-rated generic equivalent of Pfizer's Norvasc tablets.
- Ranbaxy gets tentative US nod for TamsulosinRanbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories, has received tentative approval from the U.S. Food a...
- Ranbaxy receives USFDA nod for Amlodipine BesylateCountry's biggest pharmaceutical firm Ranbaxy Laboratories on Wednesday said it has received tentative US Food and Drug Administration (USF...
Load More
